My Quote Request
6505-01-491-7003
20 Products
SULFAMYLON
MAFENIDE ACETATE CREAM,USP
NSN, MFG P/N
6505014917003
NSN
6505-01-491-7003
SULFAMYLON
MAFENIDE ACETATE CREAM,USP
NSN, MFG P/N
6505014917003
NSN
6505-01-491-7003
MFG
MYLAN BERTEK PHARMACEUTICALS INC
Description
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SULFAMYLON CREAM BRAND OF MAFENIDE ACETATE CREAM USP 20OZ TUBE
MEDICAMENT BASE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: EACH GRAM OF SULFAMYLON CREAM CONTAINS MAFENIDE ACETATE EQUIVALENT TO 85 MG OF THE BASE; SULFAMYLON EXERTS BACTERIOSTATIC ACTION AGAINST MANY GRAM NEGATIVE AND GRAM POSITIVE ORGANISMS; INDICATED FOR ADJUNCTIVE THERAPY OF PATIENTS WITH SECOND AND THIRD
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: DEGREE BURNS; AVOID EXPOSURE TO EXCESSIVE HEAT, TEMPERATURES ABOVE 104 DEG F; 2 OZ TUBE, 58.7 GRAMS
Related Searches:
6505NCM010403
MAFENIDE ACETATE CREAM,USP
NSN, MFG P/N
6505014917003
NSN
6505-01-491-7003
6505NCM010403
MAFENIDE ACETATE CREAM,USP
NSN, MFG P/N
6505014917003
NSN
6505-01-491-7003
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SULFAMYLON CREAM BRAND OF MAFENIDE ACETATE CREAM USP 20OZ TUBE
MEDICAMENT BASE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: EACH GRAM OF SULFAMYLON CREAM CONTAINS MAFENIDE ACETATE EQUIVALENT TO 85 MG OF THE BASE; SULFAMYLON EXERTS BACTERIOSTATIC ACTION AGAINST MANY GRAM NEGATIVE AND GRAM POSITIVE ORGANISMS; INDICATED FOR ADJUNCTIVE THERAPY OF PATIENTS WITH SECOND AND THIRD
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: DEGREE BURNS; AVOID EXPOSURE TO EXCESSIVE HEAT, TEMPERATURES ABOVE 104 DEG F; 2 OZ TUBE, 58.7 GRAMS
Related Searches:
NDC62794-0101-50
MAFENIDE ACETATE CREAM,USP
NSN, MFG P/N
6505014917003
NSN
6505-01-491-7003
NDC62794-0101-50
MAFENIDE ACETATE CREAM,USP
NSN, MFG P/N
6505014917003
NSN
6505-01-491-7003
MFG
MYLAN BERTEK PHARMACEUTICALS INC
Description
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SULFAMYLON CREAM BRAND OF MAFENIDE ACETATE CREAM USP 20OZ TUBE
MEDICAMENT BASE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: EACH GRAM OF SULFAMYLON CREAM CONTAINS MAFENIDE ACETATE EQUIVALENT TO 85 MG OF THE BASE; SULFAMYLON EXERTS BACTERIOSTATIC ACTION AGAINST MANY GRAM NEGATIVE AND GRAM POSITIVE ORGANISMS; INDICATED FOR ADJUNCTIVE THERAPY OF PATIENTS WITH SECOND AND THIRD
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: DEGREE BURNS; AVOID EXPOSURE TO EXCESSIVE HEAT, TEMPERATURES ABOVE 104 DEG F; 2 OZ TUBE, 58.7 GRAMS
Related Searches:
01-0580
MAFENIDE ACETATE CREAM,USP
NSN, MFG P/N
6505014917013
NSN
6505-01-491-7013
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE INGREDIENT AND STRENGTH: 8.500 MAFENIDE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SULFAMYLON CREAM BRAND OF MAFENIDE ACETATE CREAM USP 4OZ TUBE
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: EACH GRAM OF SULFAMYLON CREAM CONTAINS MAFENIDE ACETATE EQUIVALENT TO 85 MG OF THE BASE; FOR USE AS ADJUNCTIVE ANTIMICROBIAL BURN THERAPY FOR PATIENTS WITH SECOND AND THRID DEGREE BURNS; EXERTS BACTERIOSTATIC ACTION AGAINST MANY GRAM-NEGATIVE AND
SUPPLEMENTARY FEATURES: MAFENIDE CREAM
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: GRAM-POSTIVE ORGANISMS, INCLUDING PSEUDOMONAS AERUGINOSA AND CERTAIN STRAINS OF ANAEROBES; NONSTAINING; AVOID EXPOSURE TO EXCESSIVE HEAT ABOVE 104 DEGREES F OR 40 DEGREES C
Related Searches:
6505NCM010408
MAFENIDE ACETATE CREAM,USP
NSN, MFG P/N
6505014917013
NSN
6505-01-491-7013
6505NCM010408
MAFENIDE ACETATE CREAM,USP
NSN, MFG P/N
6505014917013
NSN
6505-01-491-7013
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ACTIVE INGREDIENT AND STRENGTH: 8.500 MAFENIDE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SULFAMYLON CREAM BRAND OF MAFENIDE ACETATE CREAM USP 4OZ TUBE
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: EACH GRAM OF SULFAMYLON CREAM CONTAINS MAFENIDE ACETATE EQUIVALENT TO 85 MG OF THE BASE; FOR USE AS ADJUNCTIVE ANTIMICROBIAL BURN THERAPY FOR PATIENTS WITH SECOND AND THRID DEGREE BURNS; EXERTS BACTERIOSTATIC ACTION AGAINST MANY GRAM-NEGATIVE AND
SUPPLEMENTARY FEATURES: MAFENIDE CREAM
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: GRAM-POSTIVE ORGANISMS, INCLUDING PSEUDOMONAS AERUGINOSA AND CERTAIN STRAINS OF ANAEROBES; NONSTAINING; AVOID EXPOSURE TO EXCESSIVE HEAT ABOVE 104 DEGREES F OR 40 DEGREES C
Related Searches:
NDC51079-0623-82
MAFENIDE ACETATE CREAM,USP
NSN, MFG P/N
6505014917013
NSN
6505-01-491-7013
NDC51079-0623-82
MAFENIDE ACETATE CREAM,USP
NSN, MFG P/N
6505014917013
NSN
6505-01-491-7013
MFG
UDL LABORATORIES INC
Description
ACTIVE INGREDIENT AND STRENGTH: 8.500 MAFENIDE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SULFAMYLON CREAM BRAND OF MAFENIDE ACETATE CREAM USP 4OZ TUBE
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: EACH GRAM OF SULFAMYLON CREAM CONTAINS MAFENIDE ACETATE EQUIVALENT TO 85 MG OF THE BASE; FOR USE AS ADJUNCTIVE ANTIMICROBIAL BURN THERAPY FOR PATIENTS WITH SECOND AND THRID DEGREE BURNS; EXERTS BACTERIOSTATIC ACTION AGAINST MANY GRAM-NEGATIVE AND
SUPPLEMENTARY FEATURES: MAFENIDE CREAM
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: GRAM-POSTIVE ORGANISMS, INCLUDING PSEUDOMONAS AERUGINOSA AND CERTAIN STRAINS OF ANAEROBES; NONSTAINING; AVOID EXPOSURE TO EXCESSIVE HEAT ABOVE 104 DEGREES F OR 40 DEGREES C
Related Searches:
01-0565
REHYDRATION SALTS,ORAL,MODIFIED
NSN, MFG P/N
6505014917131
NSN
6505-01-491-7131
01-0565
REHYDRATION SALTS,ORAL,MODIFIED
NSN, MFG P/N
6505014917131
NSN
6505-01-491-7131
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 230.000 MILLIGRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 156.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FLAVOR: MIXED BERRY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: REHYDRATION SALTS ORAL MODIFIED MIXED BERRY 10GM 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 GRAMS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: RICE-BASED ORAL ELECTROLYTE POWER FOR SOLUTION; CONTAINS TRISODIUM CITRATE 378 MG, AND CARBOHYDRATES 9.4 GM; FOR HELP IN PREVENTING DEHYDRATION FROM DIARRHEA IN CHILDREN AND ADULTS; CAN BE USED TO TREAT SYMPTONS FROM CHRONIC FATIGUE SYNDROME; AVAILABLE IN
TOTAL PRIMARY CONTAINER QUANTITY: 100
~1: 10 GRAM SIZE ONLY MIXED BERRY OR ORANGE FLAVOR; CAN BE MIXED WITH HOT OR COLD WATER
Related Searches:
700851-00009
REHYDRATION SALTS,ORAL,MODIFIED
NSN, MFG P/N
6505014917131
NSN
6505-01-491-7131
700851-00009
REHYDRATION SALTS,ORAL,MODIFIED
NSN, MFG P/N
6505014917131
NSN
6505-01-491-7131
MFG
CERA PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 230.000 MILLIGRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 156.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FLAVOR: MIXED BERRY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: REHYDRATION SALTS ORAL MODIFIED MIXED BERRY 10GM 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 GRAMS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: RICE-BASED ORAL ELECTROLYTE POWER FOR SOLUTION; CONTAINS TRISODIUM CITRATE 378 MG, AND CARBOHYDRATES 9.4 GM; FOR HELP IN PREVENTING DEHYDRATION FROM DIARRHEA IN CHILDREN AND ADULTS; CAN BE USED TO TREAT SYMPTONS FROM CHRONIC FATIGUE SYNDROME; AVAILABLE IN
TOTAL PRIMARY CONTAINER QUANTITY: 100
~1: 10 GRAM SIZE ONLY MIXED BERRY OR ORANGE FLAVOR; CAN BE MIXED WITH HOT OR COLD WATER
Related Searches:
CERALYTE-50
REHYDRATION SALTS,ORAL,MODIFIED
NSN, MFG P/N
6505014917131
NSN
6505-01-491-7131
CERALYTE-50
REHYDRATION SALTS,ORAL,MODIFIED
NSN, MFG P/N
6505014917131
NSN
6505-01-491-7131
MFG
CERA PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 230.000 MILLIGRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 156.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FLAVOR: MIXED BERRY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: REHYDRATION SALTS ORAL MODIFIED MIXED BERRY 10GM 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 GRAMS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: RICE-BASED ORAL ELECTROLYTE POWER FOR SOLUTION; CONTAINS TRISODIUM CITRATE 378 MG, AND CARBOHYDRATES 9.4 GM; FOR HELP IN PREVENTING DEHYDRATION FROM DIARRHEA IN CHILDREN AND ADULTS; CAN BE USED TO TREAT SYMPTONS FROM CHRONIC FATIGUE SYNDROME; AVAILABLE IN
TOTAL PRIMARY CONTAINER QUANTITY: 100
~1: 10 GRAM SIZE ONLY MIXED BERRY OR ORANGE FLAVOR; CAN BE MIXED WITH HOT OR COLD WATER
Related Searches:
NDC00851-0000-90
REHYDRATION SALTS,ORAL,MODIFIED
NSN, MFG P/N
6505014917131
NSN
6505-01-491-7131
NDC00851-0000-90
REHYDRATION SALTS,ORAL,MODIFIED
NSN, MFG P/N
6505014917131
NSN
6505-01-491-7131
MFG
CERA PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 230.000 MILLIGRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 156.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FLAVOR: MIXED BERRY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: REHYDRATION SALTS ORAL MODIFIED MIXED BERRY 10GM 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 GRAMS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: RICE-BASED ORAL ELECTROLYTE POWER FOR SOLUTION; CONTAINS TRISODIUM CITRATE 378 MG, AND CARBOHYDRATES 9.4 GM; FOR HELP IN PREVENTING DEHYDRATION FROM DIARRHEA IN CHILDREN AND ADULTS; CAN BE USED TO TREAT SYMPTONS FROM CHRONIC FATIGUE SYNDROME; AVAILABLE IN
TOTAL PRIMARY CONTAINER QUANTITY: 100
~1: 10 GRAM SIZE ONLY MIXED BERRY OR ORANGE FLAVOR; CAN BE MIXED WITH HOT OR COLD WATER
Related Searches:
01-0494
BROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014917541
NSN
6505-01-491-7541
01-0494
BROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014917541
NSN
6505-01-491-7541
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 12.000 MILLIGRAMS BROMPHENIRAMINE MALEATE ACTIVE INGREDIENT AND 120.000 MILLIGRAMS PSEUDOEPHEDRINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BROMPHENIRAMINE MALEATE & PSEUDOEPHEDRINE HCL EX-REL CAPSULES 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SUSTAINED RELEASE CAPSULES
Related Searches:
NDC58177-0019-04
BROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014917541
NSN
6505-01-491-7541
NDC58177-0019-04
BROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014917541
NSN
6505-01-491-7541
MFG
ETHEX CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 12.000 MILLIGRAMS BROMPHENIRAMINE MALEATE ACTIVE INGREDIENT AND 120.000 MILLIGRAMS PSEUDOEPHEDRINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BROMPHENIRAMINE MALEATE & PSEUDOEPHEDRINE HCL EX-REL CAPSULES 100S
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SUSTAINED RELEASE CAPSULES
Related Searches:
01-0553
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505014917570
NSN
6505-01-491-7570
01-0553
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505014917570
NSN
6505-01-491-7570
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, V/V SODIUM CHLORIDE INJECTION ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE IRRIGATION USP 50ML VIAL 100S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PRESERVATIVE FREE IN A LATEX FREE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
6505NCM010402
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505014917570
NSN
6505-01-491-7570
6505NCM010402
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505014917570
NSN
6505-01-491-7570
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, V/V SODIUM CHLORIDE INJECTION ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE IRRIGATION USP 50ML VIAL 100S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PRESERVATIVE FREE IN A LATEX FREE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00409-4888-50
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505014917570
NSN
6505-01-491-7570
NDC00409-4888-50
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505014917570
NSN
6505-01-491-7570
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, V/V SODIUM CHLORIDE INJECTION ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE IRRIGATION USP 50ML VIAL 100S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PRESERVATIVE FREE IN A LATEX FREE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
01-0560
DOBUTAMINE INJECTIO
NSN, MFG P/N
6505014917667
NSN
6505-01-491-7667
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DOBUTAMINE FOR INJECTION USP 12.5MG/ML 20ML VIAL 10S
SPECIAL FEATURES: DOBUTAMINE 12.5 MG/ML INJECTION;20 ML VIAL; 10 VIALS IN TRAY PACKS
Related Searches:
6505NCM010404
DOBUTAMINE INJECTIO
NSN, MFG P/N
6505014917667
NSN
6505-01-491-7667
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DOBUTAMINE FOR INJECTION USP 12.5MG/ML 20ML VIAL 10S
SPECIAL FEATURES: DOBUTAMINE 12.5 MG/ML INJECTION;20 ML VIAL; 10 VIALS IN TRAY PACKS
Related Searches:
NDC00074-2025-10
DOBUTAMINE INJECTIO
NSN, MFG P/N
6505014917667
NSN
6505-01-491-7667
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DOBUTAMINE FOR INJECTION USP 12.5MG/ML 20ML VIAL 10S
SPECIAL FEATURES: DOBUTAMINE 12.5 MG/ML INJECTION;20 ML VIAL; 10 VIALS IN TRAY PACKS
Related Searches:
NDC00074-2025-20
DOBUTAMINE INJECTIO
NSN, MFG P/N
6505014917667
NSN
6505-01-491-7667
MFG
ABBOTT LABORATORIES DIAGNOSTICS DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DOBUTAMINE FOR INJECTION USP 12.5MG/ML 20ML VIAL 10S
SPECIAL FEATURES: DOBUTAMINE 12.5 MG/ML INJECTION;20 ML VIAL; 10 VIALS IN TRAY PACKS
Related Searches:
NDC10019-0181-20
DOBUTAMINE INJECTIO
NSN, MFG P/N
6505014917667
NSN
6505-01-491-7667
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DOBUTAMINE FOR INJECTION USP 12.5MG/ML 20ML VIAL 10S
SPECIAL FEATURES: DOBUTAMINE 12.5 MG/ML INJECTION;20 ML VIAL; 10 VIALS IN TRAY PACKS